Skip to main content
. 2014 Oct 28;2014(10):CD007482. doi: 10.1002/14651858.CD007482.pub3

Tzingounis 1982.

Methods Randomized, placebo‐controlled trial; 2 parallel groups.
Unit of randomization: individual.
Participants Date of data collection: not reported.
Setting: Alexandra Maternity Hospital, Athens, Greece.
Inclusion criteria: women in labor (non‐elective). N = 96.
Exclusion criteria: acute bleeding due to abruptio placentae, established infection.
Interventions Intervention: 2nd generation cephalosporin:
  • cefuroxime 750 mg IV 1 hr or less before surgery and every 8 hrs for 72 hrs;

  • N = 46.


Comparison: placebo:
  • matching placebo (comparable in appearance and viscosity);

  • N = 50.

Outcomes Febrile morbidity (oral temperature of > 100.3oF twice 6 hrs apart) and infection of endometrium, urinary tract and wound (not defined); results of duration of maternal stay only provided for febrile patients.
Notes No patients had any major complications from the use of cefuroxime.
Class of antibiotic: 2nd generation cephalosporin.
Subgroups:
  • non‐elective CS;

  • before cord clamping.

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "Selected in a random manner".
Comment: no description of sequence generation process.
Allocation concealment (selection bias) Unclear risk Comment: no information was provided.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comment: no loss to follow‐up; no participants excluded. ITT analysis.
Selective reporting (reporting bias) Unclear risk Comment: insufficient information to judge.
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "double‐blind".... "the placebo was comparable to cefuroxime in both appearance and viscosity of solution".
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Comment: insufficient information to judge.
Other bias Low risk Comment: no other sources of bias identified.